00:00 Introduction to Hypertension

00:38 Welcome to Cardio Buzz

01:01 Understanding Primary Aldosteronism

02:27 Health Risks of Primary Aldosteronism

02:59 Screening for Primary Aldosteronism

05:00 Diagnosis and Interpretation

09:46 Adrenal Vein Sampling 14:22

Surgical and Medical Treatments

19:50 Conclusion and Final Thoughts

Is low blood pressure hindering your heart failure treatment? How do you balance life-saving medications with hypotension? We explore the definitions, causes, and practical solutions to optimize patient care. Learn how to navigate ARNI, beta-blockers, SGLT2 inhibitors, and MRAs effectively.

In this episode of Cardio Buzz, we explore the intriguing concept of the 'legacy effect' of medications like those used in treating diabetes, hypertension, hypercholesterolemia, and chronic kidney disease. We'll delve into landmark studies like the UKPDS, Steno-2, and more, examining the lasting impacts of medications such as Repatha, Candesartan, and Empagliflozin. Learn how these drugs contribute to disease regression, modify genes, and prevent non-fatal events to grant long-term protective effects.

00:00 Introduction: The Challenge of Lifelong Medication 00:57 Exploring the Legacy Effect of Medications

01:33 Diabetes Medications: Long-Term Benefits

03:15 Hypertension Medications: Persistent Effects

03:58 Cholesterol Medications: Lasting Impact

04:49 Kidney Disease Medications: Prolonged Benefits

06:12 Understanding the Legacy Effect Mechanism

09:13 Implications and Final Thoughts

"This week, we delve into the complexities of Familial Hypercholesterolemia (FH) diagnosis and challenge the conventional Dutch Lipid Clinic Network Score. 🩺 Our analysis of a recent Austrian study reveals significant limitations in the score's practical application, including inconsistent scoring and poor record completion. 📝

Key findings:

This episode is crucial for cardiologists and lipid specialists seeking to streamline FH screening and improve patient outcomes. 🎧 Tune in to learn more! We also discuss the need for further studies to validate this approach and assess its impact on diagnosis rates and cardiovascular outcomes. 🔬

Listen now to 'Ditching the Dutch: FH Diagnosis made easy' and join the conversation on the future of FH screening. #Cardiology #FH #Lipidology #MedicalResearch #ClinicalPractice #Diagnosis 🗣️"

Join us in this episode of Cardio Buzz as we bring you the latest updates from the European Society of Cardiology conference held in London. Discover groundbreaking clinical trials and new guidelines that promise to reshape the practice of cardiology. We will break down the ten most impactful clinical trials and four new guidelines on hypertension, chronic coronary disease, atrial fibrillation, and peripheral/aortic diseases. Stay ahead in your field with our concise and insightful analysis. Subscribe, like, and hit the notification bell to stay informed on all cardiology advancements.

00:00 Introduction to the European Society of Cardiology Conference

00:59 Top 10 Late-Breaking Clinical Trials

04:41 New Guidelines Overview

05:38 Hypertension Guidelines

09:30 Chronic Coronary Artery Disease Guidelines

15:08 Peripheral Arterial and Aortic Disease Guidelines

20:33 Atrial Fibrillation Guidelines

23:58 Conclusion and Next Steps

In this episode of Cardio Buzz, the discussion focuses on the potential of stem cell therapy to transform cardiology. Host Dr. Hussain interviews Dr. Yahya Kiwan, an experienced cardiologist and stem cell research advocate. They explore the application of stem cells in treating advanced heart conditions, including post-myocardial infarction and chronic heart failure. The episode covers the sources of stem cells, their harvesting and injection techniques, clinical trial results, and success stories. Dr. Kiwan addresses the ethical considerations and the future of regenerative medicine, emphasizing the need for greater awareness and education in the field. The episode concludes with information on upcoming educational opportunities and fellowships in regenerative cardiology.

00:48 The Promise of Stem Cells in Cardiology

01:31 Interview with Dr. Yahya Kiwan

04:13 Sources and Types of Stem Cells

05:55 Stem Cell Therapy Techniques

10:45 Current Applications and Success Stories

17:18 Future Perspectives and Ethical Considerations

19:38 Learning More About Regenerative Medicine

21:20 Conclusion and Next Steps

In this episode of CardioBuzz, host Dr. Hussien discusses advanced CPR techniques and challenges from a cardiologist's perspective, featuring Dr. Naeem Toosy, a consultant in emergency medicine. The conversation delves into critical aspects like when to stop resuscitation, use of mechanical circulatory support devices, and the effectiveness of mechanical chest compression devices. Dr. Tusi outlines the significance of early recognition, the role of the public in initiating CPR, and the potential benefits of ECMO during CPR. He underscores the need for national-level education on CPR and the importance of the Good Samaritan law in encouraging public intervention during cardiac arrests.

00:00 Introduction to CardioBuzz

00:08 Overview of CPR Challenges

00:33 Introducing Dr. Naeem Toosy

01:36 Importance of Brain Resuscitation

03:11 When to Stop Resuscitation

06:20 Mechanical Chest Compression Devices

07:49 ECMO in CPR

13:04 National Strategies to Reduce Cardiovascular Mortality

18:04 Conclusion and Final Thoughts

In this episode of Cardio Buzz, host and guest Dr. Daniel Jones discuss contrast nephropathy, a kidney injury caused by contrast agents used in medical imaging, and a promising intervention to reduce its incidence. Dr. Jones explains that inorganic nitrates, which are naturally found in green leafy vegetables, have shown significant potential in preventing contrast-induced nephropathy and associated acute kidney injuries in a recent study. This study involved 640 high-risk patients and demonstrated that inorganic nitrates reduced kidney injuries by 60% and improved long-term cardiovascular outcomes. The episode concludes with a conversation about the practical implications and future research plans for this intervention.

Microplastics are small pieces of plastic less than five millimeters in size that result from the degradation of larger plastic items. Derived from synthetic materials such as polyethylene and polyvinyl chloride, plastics are known for their durability and low cost but pose significant environmental and health risks due to their inability to biodegrade. Microplastics, including even smaller nanoplastics, are found everywhere - in our food, water, air, and even within the human body, where they can be ingested, inhaled, or absorbed through the skin. Italian researchers published their work in March 2024, found microplastics in the atherosclerotic plaques of patients with carotid artery stenosis. This presence of micro and nanoplastics was associated with higher levels of inflammation and an increased risk of heart attacks and strokes. While this finding indicates a correlation rather than causation, it raises concerns about the potential health impacts of microplastics. We provide practical advice on minimizing exposure to microplastics, such as avoiding single-use plastics, choosing products with minimal or no plastic packaging, and opting for natural fibers over synthetic ones.

00:00 Introduction to Plastics: Types and Properties

00:26 The Environmental and Health Impact of Microplastics

01:39 Investigating Microplastics in Human Arteries: A Groundbreaking Study

02:25 Study Findings: Microplastics in Atherosclerotic Plaques

03:12 Implications of the Study: Association vs. Causation

03:44 Practical Steps to Minimize Microplastic Exposure

04:47 Conclusion: The Challenge of Avoiding Microplastics